Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Sales | 212,405 | 173,925 | 125,706 | 77,899 | 65,264 |
| Gross Profit | 212,405 | 173,925 | 125,706 | 77,899 | 65,264 |
| Operating Expenses | 103,638 | 71,039 | 47,681 | 40,973 | 43,488 |
| Operating Income | 108,767 | 102,886 | 78,025 | 36,926 | 21,776 |
| Interest Expense | 36,000 | 28,796 | 16,139 | 5,278 | 4,311 |
| Other Income | -1,190 | 9 | 12 | 109 | 10 |
| Pre-tax Income | 71,577 | 74,099 | 61,898 | 31,757 | 17,475 |
| Income Tax | 7,057 | 9,818 | 11,084 | 3,555 | 3,919 |
| Net Income Continuous | 64,520 | 64,281 | 50,814 | 28,202 | 13,556 |
| Minority Interests | 594 | 816 | 625 | -181 | 0 |
| Net Income | $63,926 | $63,465 | $50,189 | $28,383 | $13,556 |
| EPS Basic Total Ops | 2.89 | 3.26 | 2.60 | 1.58 | 0.76 |
| EPS Basic Continuous Ops | 2.91 | 3.30 | 2.63 | 1.57 | 0.76 |
| EPS Diluted Total Ops | 2.82 | 3.18 | 2.55 | 1.56 | 0.76 |
| EPS Diluted Continuous Ops | 2.85 | 3.22 | 2.58 | 1.55 | 0.76 |
| EBITDA(a) | $180,958 | $155,280 | $114,778 | $60,008 | $41,290 |